Foster common approaches between People’s Republic of China and the European Union on Personalised Medicine research, development, innovation and policies
News
Check it out: IC2PErMed New publication in Future Medecine
IC2PerMed’s article “Research and innovation in personalized medicine: a descriptive synthesis of actors in the EU and China” has [...]
IC2PERMED European and Chinese partners gathered for the first time in Italy
From 17 to 20 April 2023, in the framework of the IC2PerMed project, the first visit of [...]
IC2PerMed Chinese delegates are coming to Italy!
Following three years of strict online interaction and collaboration, the Chinese and European partners of the [...]
IC2PerMed at a glance
Supporting International collaboration for the development of Personalised Medicine
The International Consortium for Personalised Medicine (ICPerMed), umbrella initiative of IC2PerMed, aims at initiating and supporting communication and exchange on Personalised Medicine (PM) for aligning national agendas on research and funding activities. It brings together representatives of funding agencies and authorities from 29 countries and expands for increasing PM developments’ synergies at international level.
IC2PerMed project’s core objective is to build upon collaborative developments of Chinese and European experts on PM for elaborating a common strategy, enabling Chinese institutions to join the ICPerMed consortium. The 3 Expert Working Groups will set the path for a common approach of PM research, innovation, development and implementation over the project duration.
